Patents

You are browsing the archives of "Patents."

STLR Link Roundup – October 14, 2011

This week, Aurobindo Pharma became the first major generic drugmaker to join a patent pool designed to increase accessibility of AIDS/HIV treatments to the poor around the world. Lawmakers from across the country have written the Obama Administration in hopes of housing new satellite branches of the Patent and Trademark Office in their respective districts. [...]

STLR Link RoundUp – October 07, 2011

Tech visionary Steve Jobs passed away on October 5, 2011. His name was listed on 317 Apple patents, including the Macintosh, the iPod, the iPhone, and the iPad. Sprint is urging the FCC to quickly hold hearings to rule on whether the transfer of spectrum licenses from T-Mobile to AT&T serves the public interest. AT&T’s [...]

Must Office Actions Be Disclosed to the PTO under Rule 56?

Inequitable Conduct and the Duty to Disclose 37 CFR 1.56 (Rule 56) establishes that there is a duty to disclose information to the Patent Office. The regulation states that “[e]ach individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which [...]

The Active Placebo Effect: Patent Eligible Subject Matter?

Last week President Barack Obama asked a bioethics committee to review federal guidelines for the use of human subjects in medical testing. This announcement came in the wake of revelations that the U.S. sponsored experiments in Guatemala the 1940s where people were intentionally infected with sexually transmitted diseases like syphilis and gonorrhea without their consent [...]

USPTO to Implement New Quality Measurement System

The United States Patent and Trademark Office (USPTO) recently announced that it will be implementing a new system for measuring the quality of patent examination at the start of fiscal year 2011.  This system is designed to provide a more comprehensive analysis of patent examination to better enable its participants to identify and follow its [...]

STLR Link Roundup – August 2, 2010

The latest links from STLR: The Copyright Office released its latest group of exceptions to the Digital Millenium Copyright Act’s anti-circumvention provision. Wired and cnet news report on the exception for jailbreaking mobile phones. Also in DMCA news, Ars Technica discusses the Fifth Circuit decision that bypassing technological protections to access software for a fair use does [...]

Court Allows Challenge to Patents on Breast Cancer Genes

Judge Robert Sweet in the U.S. District Court for the Southern District of New York has allowed a challenge to two gene patents owned by Myriad Genetics.  The ACLU, on behalf of scientific organizations, researchers, genetic counselors, and individual women, is contesting the validity of gene patents in general, and is challenging the patents on [...]

STLR Link Roundup – November 13, 2009

The latest on the STLR radar: Bloomberg reports that Yahoo has settled a lawsuit that accused the Internet search company of allowing unauthorized resellers of Mary Kay products use Mary Kay’s logos in pop-up advertisements. Facebook is sued again for being too free with your personal information: Wired.com’s Threat Level blogs that a Texas woman [...]

Recap: Bilski Oral Argument at Supreme Court

The U.S. Supreme Court heard oral arguments on Monday in Bilski v. Kappos, which will require it to rule on the patentability of a method of hedging risks in commodities trading.  Michael Jakes of Finnegan, Henderson, Farabow, Garrett & Dunner represented Petitioner Bilski, and Malcolm Stewart, assistant to the U.S. Solicitor General, represented Respondent Kappos [...]

STLR Link Roundup – November 6, 2009

The latest on the STLR radar: Patently-O wonders whether the Supreme Court might take the opportunity afforded by the upcoming Bilski method patent case to scrap software patents, and states the socio-economic case for abandoning them. Engineering crime scenes: Lawyers.com considers a study which suggests that fabricating DNA evidence is far from science fiction. On [...]